Optimization of Treatment of Advanced Nonsmall Cell Lung Cancer Using Radiotherapy and Chemotherapy
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
Primary objectives of the study are:
To assess the differences in survival of the two treatment options in both stage III (A and
B) nonsmall cell lung cancer (NSCLC) (Study A) and Stage IIIB (wet) and stage IV NSCLC (Study
B), respectively
Secondary objectives are:
To assess the differences in toxicity of two treatment options in both stage III (A and B)
NSCLC (Study A) and Stage IIIB (wet) and stage IV NSCLC (Study B), and To assess the
differences in Health Related Quality of Life (HRQoL) of two treatment options in both Study
A and Study B